Results for tag: "Milrinone"

Milrinone is a cardiovascular drug used to treat heart failure and other cardiac conditions. It is a type of inotropic agent, meaning it increases the force of contraction of the heart muscle. It is administered intravenously and is used to improve cardiac output and reduce pulmonary congestion. Milrinone is also used to treat cardiogenic shock, a life-threatening condition in which the heart is unable to pump enough blood to meet the body's needs. Milrinone is a relatively new drug, having been approved by the FDA in 1991. It is used in both inpatient and outpatient settings, and is often used in combination with other drugs to treat heart failure. The Milrinone market is highly competitive, with several major pharmaceutical companies producing and marketing the drug. These include Pfizer, Novartis, Merck, and Sanofi. Other companies, such as Mylan and Teva, also produce generic versions of the drug. Show Less Read more